Literature DB >> 22744639

Personalized medicine in pancreatic cancer: prognosis and potential implications for therapy.

Christine A Iacobuzio-Donahue1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22744639      PMCID： PMC3556913          DOI： 10.1007/s11605-012-1943-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  21 in total

1.  TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses.

Authors:  Li Yu; Mindy C Hébert; Ying E Zhang
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

2.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 3.  The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting.

Authors:  Scott E Kern; Chanjuan Shi; Ralph H Hruban
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

4.  Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.

Authors:  Erlinda E Embuscado; Daniel Laheru; Francesca Ricci; Ki Jung Yun; Sten de Boom Witzel; Allison Seigel; Katie Flickinger; Manuel Hidalgo; G Steven Bova; Christine A Iacobuzio-Donahue
Journal:  Cancer Biol Ther       Date:  2005-05-12       Impact factor: 4.742

5.  Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.

Authors:  Kerstin Jungert; Anita Buck; Götz von Wichert; Guido Adler; Alexander König; Malte Buchholz; Thomas M Gress; Volker Ellenrieder
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

6.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

7.  Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells.

Authors:  J L Dai; M Schutte; R K Bansal; R E Wilentz; A Y Sugar; S E Kern
Journal:  Mol Carcinog       Date:  1999-09       Impact factor: 4.784

8.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 9.  Non-Smad TGF-beta signals.

Authors:  Aristidis Moustakas; Carl-Henrik Heldin
Journal:  J Cell Sci       Date:  2005-08-15       Impact factor: 5.285

Review 10.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962
View more
  1 in total

1.  Smart surface for elution of protein-protein bound particles: nanonewton dielectrophoretic forces using atomic layer deposited oxides.

Authors:  Sam Emaminejad; Mehdi Javanmard; Robert W Dutton; Ronald W Davis
Journal:  Anal Chem       Date:  2012-12-06       Impact factor: 6.986
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.